LANIA, Andrea Gerardo Antonio
 Distribuzione geografica
Continente #
NA - Nord America 5.661
EU - Europa 1.125
AS - Asia 323
AF - Africa 192
SA - Sud America 18
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 5
Totale 7.332
Nazione #
US - Stati Uniti d'America 5.643
FI - Finlandia 332
IE - Irlanda 236
NG - Nigeria 191
CN - Cina 154
FR - Francia 121
DE - Germania 102
SG - Singapore 84
NL - Olanda 79
IT - Italia 75
GB - Regno Unito 48
SE - Svezia 41
IN - India 36
MK - Macedonia 16
BE - Belgio 15
PK - Pakistan 15
RU - Federazione Russa 15
CA - Canada 14
CL - Cile 10
IL - Israele 9
TR - Turchia 9
UA - Ucraina 9
AU - Australia 7
CH - Svizzera 6
HU - Ungheria 6
PH - Filippine 6
RO - Romania 6
BR - Brasile 5
GR - Grecia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
IR - Iran 3
PL - Polonia 3
AR - Argentina 2
AT - Austria 2
BD - Bangladesh 2
EE - Estonia 2
ES - Italia 2
EU - Europa 2
KR - Corea 2
MX - Messico 2
PA - Panama 2
IS - Islanda 1
JP - Giappone 1
KZ - Kazakistan 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
UG - Uganda 1
Totale 7.332
Città #
Chandler 1.207
Wilmington 1.051
San Mateo 402
Ann Arbor 337
Helsinki 332
New York 244
Dublin 235
Lawrence 204
Princeton 204
Benin City 191
Boardman 183
Leawood 179
Shanghai 141
Paris 119
Ashburn 116
Fairfield 87
Woodbridge 82
Singapore 81
Amsterdam 59
London 44
Pune 33
Milan 28
Norwalk 22
San Diego 18
Santa Clara 18
Seattle 17
Brussels 15
Lahore 14
Los Angeles 14
Phoenix 12
Toronto 11
Abbiategrasso 9
Falkenstein 9
Kocaeli 9
Skopje 8
Hanover 6
Monmouth Junction 6
Redmond 6
Beijing 5
Bitola 5
Clearwater 5
Falls Church 5
Moscow 5
Rome 5
Dronten 4
Houston 4
São Paulo 4
Andover 3
Budapest 3
Des Moines 3
Frankfurt am Main 3
Henderson 3
Many 3
Novokuznetsk 3
Olongapo City 3
Pavia 3
Prilep 3
Redwood City 3
Riverview 3
Apo 2
Athens 2
Buenos Aires 2
Canberra 2
Cesano Boscone 2
Dhaka 2
Eden Prairie 2
Erbusco 2
Gdansk 2
Geneva 2
Genoa 2
Jerusalem 2
Kemerovo 2
Kochi 2
Las Pinas 2
Nanjing 2
Palazzolo sull'Oglio 2
Portland 2
Puebla 2
Sale Marasino 2
San Francisco 2
San Jose 2
Tallinn 2
Turi 2
Venegono Superiore 2
Washington 2
Addison 1
Adelaide 1
Agrate Brianza 1
Almaty 1
Cagayan de Oro 1
Chicago 1
Chisinau 1
Dearborn 1
Durham 1
Ferrara 1
Florence 1
Fort Worth 1
Gallarate 1
Gunzenhausen 1
Göttingen 1
Totale 5.898
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 113
G protein mutations in endocrine diseases 64
A 2019 update on TSH-secreting pituitary adenomas 64
Parental origin of G(s)alpha mutations in the McCune-Albright syndrome and in isolated endocrine tumors 61
A Rare Case of Cushing Syndrome Caused by an Ectopic ACTH-Secreting Pancreatic Neuroendocrine Tumor in a Patient with Von Hipple-Lindau Disease 60
Analysis of GNAS1 and PRKAR1A gene mutations in human cardiac myxomas not associated with multiple endocrine disorders 58
Growth factors and human pituitary adenomas 58
G-Protein and Signalling in Pituitary Tumours 55
FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression 55
A potential catastrophic trap: an unusually presenting sellar lesion 54
G protein abnormalities in pituitary adenomas 54
Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac) 53
Functional hypothalamic and drug-induced amenorrhea: an overview 52
d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype 52
Activating mutations of the G(s)alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors 52
The trans-sphenoidal resection of pituitary adenomas in elderly patients and surgical risk 52
Hormonal signaling and pituitary adenomas 51
Abacavir, nevirapine, and ritonavir modulate intracellular calcium levels without affecting GHRH-mediated growth hormone secretion in somatotropic cells in vitro 51
Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients 49
Bone disorders associated with acromegaly: mechanisms and treatment 49
Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation 49
An Unusual Case of Recurrent Autoimmune Hypophysitis 49
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 49
Central hypothyroidism and growth hormone treatment : clinical care 48
Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident 48
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas 48
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 48
Growth hormone replacement therapy in growth hormone deficient children and adults: Effects on hemochrome 47
Central hypothyroidism 47
A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal 47
Long-term basal and dynamic evaluation of hypothalamic-pituitary-adrenal (HPA) axis in acromegalic patients 47
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly 47
Medullary thyroid carcinoma treated with percutaneous ultrasound-guided radiofrequency ablation 47
Artificial intelligence-based radiomics on computed tomography of lumbar spine in subjects with fragility vertebral fractures 46
Central hypothyroidism - a neglected thyroid disorder 46
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 46
Levothyroxine supplementation on assisted reproduction technology (ART) outcomes in women with subtle hypothyroidism: a retrospective study 46
A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment 45
Different expression of protein kinase A (PKA) regulatory subunits in normal and neoplastic thyroid tissues 45
Adequacy of current postglucose GH nadir limit (< 1 mu g/1) to define long-lasting remission of acromegalic disease 45
Expression of the anti-apoptotic factor seladin-1 and induction of apoptosis in GH secreting adenomas and in non-functioning pituitary adenomas 45
Expression of calcium-sensing receptor and characterization of intracellular signaling in human pituitary adenomas 44
Filamin-A Is Essential for Dopamine D2 Receptor Expression and Signaling in Tumorous Lactotrophs 44
Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients 44
Genetics of pituitary tumors: Focus on G-protein mutations 43
cAMP in the pituitary: An old messenger for multiple signals 43
Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands 43
Pituitary incidentalomas 42
Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas 42
Biallelic expression of the Gs alpha gene in human bone and adipose tissue 42
cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells 42
Endoscopic expanded endonasal approach: preliminary experience with the new 3D endoscope 42
Expression of protein kinase A regulatory subunits in benign and malignant human thyroid tissues : a systematic review 42
Un caso di carcinoma neuroendocrino del timo determinante sindrome di Cushing da ACTH ectopico 42
High bone marrow fat in patients with Cushing's syndrome and vertebral fractures. 42
Effect of cyclic adenosine 3 ',5 '-monophosphate/protein kinase A pathway on markers of cell proliferation in nonfunctioning pituitary adenomas 42
Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours 42
Mechanisms of disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases 42
Inactivating and activating mutations of the Gs alpha gene 42
Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy 42
Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease 41
GNAS imprinting and pituitary tumors 41
Growth Hormone Receptor Variants and Response to Pegvisomant in Monotherapy or in Combination with Somatostatin Analogs in Acromegalic Patients: A Multicenter Study 41
Effects of hypothalamic neuropeptides on extracellular signal-regulated kinase (ERK1 and ERK2) cascade in human tumoral pituitary cells 41
Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors 41
Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia 41
The Number of Metastatic Lymph Nodes is a Useful Predictive Factor for Recurrence after Surgery for Nonmetastatic Nonfunctional Neuroendocrine Neoplasm of the Pancreas 41
GH Replacement Improves Quality of Life and Metabolic Parameters in Cured Acromegalic Patients with Growth Hormone Deficiency 41
High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells 41
Peripheral insulin-like factor 3 concentrations are reduced in men with type 2 diabetes mellitus: effect of glycemic control and visceral adiposity on Leydig cell function 41
Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors 40
Focus on GH deficiency and thyroid function 40
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 40
Evaluation of proopiomelanocortin mRNA in the peripheral blood from patients with Cushing's syndrome of different origin 39
Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors 39
Screening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma 39
Double Pituitary and Conserved Function in an Adult Patient with Neurofibromatosis Type 1 39
Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks 39
Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression 39
Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment 39
Correction to: Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 39
Thyrotoxicosis in patients with COVID-19: the THYRCOV study 39
Evolution of an Aggressive Prolactinoma into a Growth Hormone Secreting Pituitary Tumor Coincident with GNAS Gene Mutation 38
GH Response to Oral Glucose Tolerance Test: A Comparison between Patients with Acromegaly and Other Pituitary Disorders 38
Mutational analysis of PRKAR1A and Gs alpha in sporadic adrenocortical tumors 38
Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy 38
Identification of human somatostatin receptor 2 domains involved in internalization and signaling in QGP-1 pancreatic neuroendocrine tumor cell line 38
Dopamine receptor type 2 (DRD2) inhibits migration and invasion of human tumorous pituitary cells through ROCK-mediated cofilin inactivation 38
Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy 38
cAMP effects in neuroendocrine tumors: The role of Epac and PKA in cell proliferation and adhesion 37
Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly 37
Is the 250 mu g ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders? 37
Impact of IGF(CA)19 gene polymorphism on the metabolic response to GH therapy in adult GH-deficient patients 37
The benefit of statins in SARS-CoV-2 patients: further metabolic and prospective clinical studies are needed 37
Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece in the COVID puzzle 37
Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas 36
Complete Remission of Hepatic Metastasis after Total Gastrectomy for a Gastric Carcinoid Tumor Type 1: A Case Report 36
Growth hormone-releasing hexapeptide (GHRP-6) increases intracellular calcium concentrations in cultured cells from human pituitary adenomas of different types 36
Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors 36
Pegvisomant in acromegaly: an update 36
Totale 4.498
Categoria #
all - tutte 59.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.662


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/20211.831 6 24 9 15 15 624 252 154 352 173 10 197
2021/20221.008 31 5 7 226 7 8 32 132 143 115 237 65
2022/20233.127 448 141 308 348 287 268 25 253 536 291 178 44
2023/20241.540 122 203 333 112 44 269 103 105 48 28 173 0
Totale 7.507